DZ Bank
AKBA icon

DZ Bank’s Akebia Therapeutics AKBA Stock Holding History

DZ Bank’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-92,554
Closed -$169K – 1026
2024
Q1 		$169K Buy
+92,554
New +$148K ﹤0.01% 893

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

DZ Bank's AKBA Position: Q2 2024 in Review

DZ Bank sold out of Akebia Therapeutics (AKBA) in Q2 2024, closing a stake of 92,554 shares — an estimated $169K sold.

DZ Bank first reported a position in AKBA in Q1 2024 and held it in 1 quarter. The position peaked at $169K in Q1 2024. 103 funds tracked by Wall St. Rank hold AKBA as of Q2 2024.

  • DZ Bank reported no remaining Akebia Therapeutics position as of Q2 2024 after selling out during the quarter.
  • DZ Bank sold 92,554 Akebia Therapeutics shares in Q2 2024, an estimated $169K.
  • DZ Bank first reported a position in Akebia Therapeutics in Q1 2024 and held it in 1 quarter.
  • DZ Bank's Akebia Therapeutics position peaked at $169K in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2024.

Based on DZ Bank's 13F filing for Q2 2024, filed 14 Aug 2024.